Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In the transition from normal glucose tolerance (NGT) to type 2 diabetes mellitus (T2DM), the role of β-cell dysfunction and peripheral insulin resistance (IR) is well established. However, the impact of dysfunctional adipose tissue has not been fully elucidated. The aim of this study was to evaluate the role of resistance to the antilipolytic effect of insulin (adipose tissue IR [Adipo-IR]) in a large group of subjects with NGT, impaired glucose tolerance (IGT), and T2DM. Three hundred two subjects with varying glucose tolerance received an oral glucose tolerance test (OGTT) and euglycemic insulin clamp. We evaluated Adipo-IR (fasting and mean OGTT plasma free fatty acid [FFA] × insulin concentrations), peripheral IR (1/[Matsuda index] and (M/I)−1 value), and β-cell function (calculated as the ratio of the increment in plasma insulin to glucose [OGTT/IR (ΔI/ΔG ÷ IR)]). Fasting Adipo-IR was increased twofold in obese subjects with NGT and IGT versus lean subjects with NGT (8.0 ± 1.1 and 9.2 ± 0.7 vs. 4.1 ± 0.3, respectively) and threefold in subjects with T2DM (11.9 ± 0.6; P < 0.001). Progressive decline in ΔI/ΔG ÷ IR was associated with a progressive impairment in FFA suppression during OGTT, whereas the rise in mean plasma glucose concentration only became manifest when subjects became overtly diabetic. The progressive decline in β-cell function that begins in individuals with NGT is associated with a progressive increase in FFA and fasting Adipo-IR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in the presence of Adipo-IR, FFA release is not suppressed despite high insulin concentrations.45”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [45]
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Data Analysis Insulin sensitivity was assessed by Matsuda index (32) from the plasma glucose and insulin concentrations measured during the OGTT.”
MethodSelf-citationAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743 · cited 1×
“Thus, with progression from lean NGT to obese NGT to IGT, the insulin secretion/insulin resistance (disposition) index declined and was closely related to the deterioration in OGTT, consistent with previous studies from our group and others (31,34,39,40).”
ResultMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050 · cited 1×
“, the impaired suppression of lipolysis in the presence of high insulin levels, has been associated with glucose intolerance, and elevated plasma FFA have been shown to impair muscle insulin signaling, promote hepatic gluconeogenesis, and impair glucose-stimulated insulin response (7-13).”
BackgroundSelf-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
ResultBoden, G. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.007 · Cited by 853 · cited 1×
“Insulin acts on adipose tissue 1) by stimulating glucose uptake and triglyceride synthesis and 2) by suppressing triglyceride hydrolysis and release of FFA and glycerol into the circulation (6,7).”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 4×
“In contrast to the OGTT, studies with the stepped hyperinsulinemic clamp consistently have demonstrated impaired suppression of plasma FFA and glycerol concentrations and (14)C-palmitate turnover (18,22,24) (i.”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Insulin acts on adipose tissue in two different ways: (1) stimulating glucose uptake and triglyceride synthesis; and (2) suppressing triglyceride hydrolysis and inducing the uptake of FFA and glycerol from circulation [165].”
BackgroundMechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Adipose-tissue plasticity in health and disease
Sakers, A., De Siqueira, M. K., Seale, P., & Villanueva, C. J. (2022) · Cell · doi:10.1016/j.cell.2021.12.016 · Cited by 1,026
“In the fed state, adipose-tissue metabolic inflexibility manifests as insulin resistance, resulting in decreased postprandial glucose and lipid sequestration, unrestrained lipolysis, and elevated circulating FFA levels (Gastaldelli et al., 2017; Petersen and Shulman, 2018).”
BackgroundWhy does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
Self-citationBello-Chavolla, O. Y., Almeda-Valdes, P., Gomez-Velasco, D., Viveros-Ruiz, T., Cruz-Bautista, I., Romo-Romo, A., Sánchez-Lázaro, D., Meza-Oviedo, D., Vargas-Vázquez, A., Campos, O. A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0883 · Cited by 664
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
Zaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455
“Role of dysfunctional adipose tissue and lipotoxicity Increased adiposity, as often found in NAFLD and T2D, is associated with adipocyte IR and dysfunction.(7,13,51) This results in excess FFA release into the blood stream and predisposes to lipotoxicity,”
BackgroundSelf-citationInsulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155142 · Cited by 330
Self-citationMeasuring and estimating insulin resistance in clinical and research settings
Gastaldelli, A. (2022) · Obesity · doi:10.1002/oby.23503 · Cited by 244
Self-citationPioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes
DeFronzo, R. A., Inzucchi, S., Abdul-Ghani, M., & Nissen, S. E. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118825376 · Cited by 223
Self-citationGutiérrez-Cuevas, J., Santos, A., & Armendariz-Borunda, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111629 · Cited by 216
Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links
Zafar, U., Khaliq, S., Ahmad, H. U., Manzoor, S., & Lone, K. P. (2018) · Hormones · doi:10.1007/s42000-018-0051-3 · Cited by 221
The interplay of factors in metabolic syndrome: understanding its roots and complexity
Islam, M. S., Wei, P., Suzauddula, M., Nime, I., Feroz, F., Acharjee, M., & Pan, F. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01019-y · Cited by 169
Xiao, H., Sun, X., Lin, Z., Yang, Y., Zhang, M., Xu, Z., Liu, P., Liu, Z., & Huang, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.023 · Cited by 194
Kunz, H., Hart, C. R., Gries, K. J., Parvizi, M., LAURENTI, M. C., Man, C. D., Moore, N., Zhang, X., Ryan, Z., Polley, E. C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00070.2021 · Cited by 189
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“45 The combination of high FFA fl ux and high insulin promotes the uptake and re-esteri fi cation of FFAs into TAGs by peripheral tissues, including the liver, 11,46 and has been associated with worse histology and increased fi brosis.”
Self-citationChen, Y. Q., Pottanat, T. G., Siegel, R. W., Ehsani, M., Qian, Y.-W., Zhen, E. Y., Regmi, A., Roell, W. C., Guo, H., Luo, M. J., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000781 · Cited by 147
“The excess adiposity causes insulin resistance (mainly in skeletal muscle through incompletely understood mechanisms) and hypertension (by increasing the arterial resistance) (27–37).”
The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function
Chen, X., Ayala, I., Shannon, C. E., Fourcaudot, M. J., Acharya, N., Jenkinson, C. P., Heikkinen, S., & Norton, L. (2018) · Diabetes · doi:10.2337/db17-0318 · Cited by 143
“Fasting Adipo-IR was calculated from free fatty acid and insulin data (24).”
MethodFryk, E., Olausson, J., Mossberg, K., Strindberg, L., Schmelz, M., Brogren, H., Gan, L., Piazza, S., Provenzani, A., Becattini, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103264 · Cited by 163
Zhang, P., Mo, D.-G., Zeng, W., & Dai, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02642-7 · Cited by 153
“Fatty acids resulting from lipolysis trigger the pro-inflammatory serine kinase cascade and release inflammatory mediators such as C reactive protein while simultaneously correlating with diminished β-cell activity and heightened IR [56, 57].”
Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives
Borse, S., Chhipa, A. S., Sharma, V., Singh, D. P., & Nivsarkar, M. (2020) · Medical Principles and Practice · doi:10.1159/000511002 · Cited by 172
Saponaro, C., Sabatini, S., Gaggini, M., Carli, F., Rosso, C., Positano, V., Armandi, A., Caviglia, G. P., Faletti, R., Bugianesi, E., et al. (2022) · Liver International · doi:10.1111/liv.15377 · Cited by 116
Self-citationMacGregor, K. A., Gallagher, I. J., & Moran, C. N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab415 · Cited by 128
Kim, J. Y., Bacha, F. F., Tfayli, H. M., Michaliszyn, S. F., Yousuf, S., & Arslanian, S. A. (2018) · Diabetes Care · doi:10.2337/dc18-1178 · Cited by 119
Fang, J., Yang, L., Xie, H., Farag, M. A., Feng, S., Li, J., & Shao, P. (2022) · Food Chemistry X · doi:10.1016/j.fochx.2022.100207 · Cited by 120
Gastaldelli, A., Sabatini, S., Carli, F., Gaggini, M., Bril, F., Belfort‐DeAguiar, R., Positano, V., Barb, D., Kadiyala, S., Harrison, S., et al. (2021) · Liver International · doi:10.1111/liv.15005 · Cited by 101
Self-citationBeneficial Effects of Pomegranate on Lipid Metabolism in Metabolic Disorders
Hou, C., Zhang, W., Li, J., Du, L., Lv, O., Zhao, S., & Li, J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800773 · Cited by 113
Vesković, M. N., Šutulović, N., Hrnčić, D., Stanojlović, O. P., Μacut, D., & Mladenović, D. R. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110570 · Cited by 115
“Adiponectin also reduces the influx of free fatty acids (FFAs) in the liver and prevents steatosis development through 5–AMP kinase inhibiting acetyl-CoA decarboxylase (ACC) and fatty synthase [62,63].”
BackgroundMetabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
Yee, L. D., Mortimer, J. E., Natarajan, R. D., Dietze, E. C., & Seewaldt, V. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00058 · Cited by 113
Extracellular vesicles as signaling mediators in type 2 diabetes mellitus
Hooten, N. N., & Evans, M. K. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00536.2019 · Cited by 101
Carpentier, A. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2020 · Cited by 108
Management of Obesity in Cardiovascular Practice
Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.035 · Cited by 87
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 111
Borujeni, M. J. S., Esfandiary, E., Baradaran, A., Valiani, A., Ghanadian, M., Codoñer‐Franch, P., Basirat, R., Alonso‐Iglesias, E., Mirzaei, H., & Yazdani, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27755 · Cited by 91
“IR plays a crucial role in worsening of condition in obese and subjects with T2D (Gastaldelli et al., 2017).”
BackgroundDella Pepa, G., Russo, M., Vitale, M., Carli, F., Vetrani, C., Masulli, M., Riccardi, G., Vaccaro, O., Gastaldelli, A., Rivellese, A. A., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108984 · Cited by 84
Self-citationArmenise, C., Lefebvre, G. C., Carayol, J., Bonnel, S., Bolton, J. L., Cara, A. D., Gheldof, N., Descombes, P., Langin, D., Saris, W. H. M., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156216 · Cited by 88
Liu, X., Abudukeremu, A., Jiang, Y., Cao, Z., Wu, M., Ma, J., Sun, R., He, W., Chen, Z., Chen, Y., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01777-9 · Cited by 83
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance
Gastaldelli, A., Abdul Ghani, M., & DeFronzo, R. A. (2021) · Diabetes · doi:10.2337/db19-1152 · Cited by 75
Self-citationMultitargeted Effects of Vitexin and Isovitexin on Diabetes Mellitus and Its Complications
Abdulai, I. L., Kwofie, S. K., Gbewonyo, W. S. K., Boison, D., Puplampu, J. B., & Adinortey, M. B. (2021) · The Scientific World JOURNAL · doi:10.1155/2021/6641128 · Cited by 82
“However, excessive adiposity is associated with adverse conditions such as obesity and DM [49].”
BackgroundRelationship of obesity to adipose tissue insulin resistance
Jiang, J., Cai, X., Pan, Y., Du, X., Zhu, H., Yang, X., Zheng, D., Gaisano, H., Wei, T., & He, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000741 · Cited by 73
Andersson-Hall, U. K., Gustavsson, C., Pedersen, A., Malmodin, D., Joelsson, L., & Holmäng, A. B. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4207067 · Cited by 91
Kupriyanova, Y., Zaharia, O. P., Bobrov, P., Karusheva, Y., Burkart, V., Szendroedi, J., Hwang, J.-H., Roden, M., Roden, M., Al-Hasani, H., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.030 · Cited by 70
Zaharia, O. P., Strassburger, K., Knebel, B., Kupriyanova, Y., Karusheva, Y., Wolkersdorfer, M., Bódis, K., Markgraf, D. F., Burkart, V., Hwang, J.-H., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0329 · Cited by 71
“In conclusion, patients of the SIRD cluster are more frequently carriers of the G allele in the PNPLA3 gene, which associates with increased circulating FFA levels and adipose tissue insulin resistance.”
BackgroundInfluentialFalkevall, A., Mehlem, A., Folestad, E. B., Ning, F. C., Osorio-Conles, Ó., Radmann, R., de Hollanda, A., Wright, S. D., Scotney, P. D., Nash, A. D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.014 · Cited by 72
Bian, C., Bai, B., Gao, Q., Li, S., & Zhao, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00531 · Cited by 66
In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update
Kury, L. T. A., Abdoh, A., Ikbariah, K., Sadek, B. S., & Mahgoub, M. (2021) · Molecules · doi:10.3390/molecules27010182 · Cited by 78
“On the contrary, high levels of free fatty acids in the bloodstream can lead to their accumulation in other organs such as the liver, which eventually affects insulin sensitivity and hepatic gluconeogenesis and worsens T2DM [39,41].”
BackgroundDietary triterpenes in the treatment of type 2 diabetes: To date
Teng, H., Yuan, B., Gothai, S., Arulselvan, P., Song, X., & Chen, L. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.11.012 · Cited by 69
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Self-citationGancheva, S., Kahl, S., Pesta, D., Mastrototaro, L., Dewidar, B., Strassburger, K., Sabah, E., Esposito, I., Weiß, J., Sarabhai, T., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1758 · Cited by 60
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Enooku, K., Tsutsumi, T., Kondo, M., Fujiwara, N., Sasako, T., Shibahara, J., Kado, A., Okushin, K., Fujinaga, H., Nakagomi, R., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01633-2 · Cited by 62
Xuan, X., Hamaguchi, M., Cao, Q., Okamura, T., Hashimoto, Y., Obora, A., Kojima, T., Fukui, M., Yuan, G., Guo, Z., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.037 · Cited by 64
Kim, J. Y., Nasr, A., Tfayli, H. M., Bacha, F. F., Michaliszyn, S. F., & Arslanian, S. A. (2017) · Diabetes · doi:10.2337/db17-0551 · Cited by 63
Role of RAGE in obesity-induced adipose tissue inflammation and insulin resistance
Feng, Z., Du, Z., Shu, X. Y., Zhu, L., Wu, J., Gao, Q., Wang, L., Chen, N., Li, Y., Luo, M., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00711-w · Cited by 62
Obese zebrafish: A small fish for a major human health condition
Faillaci, F., Milosa, F., Critelli, R. M., Turola, E., Schepis, F., & Villa, E. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12042 · Cited by 64
Antonio‐Villa, N. E., Juárez-Rojas, J. G., Posadas‐Sánchez, R., Reyes-Barrera, J., & Medina-Urrutia, A. X. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01807-6 · Cited by 54
Relation of the degree of obesity in childhood to adipose tissue insulin resistance
Hagman, E., Besor, O., Hershkop, K., Santoro, N., Pierpont, B., Mata, M., Caprio, S., & Weiss, R. (2019) · Acta Diabetologica · doi:10.1007/s00592-018-01285-3 · Cited by 51
Muscle aging and sarcopenia: The pathology, etiology, and most promising therapeutic targets
Grima-Terrén, M., Campanario, S., Ramírez‐Pardo, I., Cisneros, A., Hong, X., Perdiguero, E., Serrano, A. L., Isern, J., & Muñoz‐Cánoves, P. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101319 · Cited by 61
Čížková, T., Štěpán, M., Daďová, K., Ondrůjová, B., Sontáková, L., Krauzová, E., Matouš, M., Koc, M., Gojda, J., Kračmerová, J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa630 · Cited by 46
Zhang, M., Liu, D., Qin, P., Liu, Y., Sun, X., Li, H., Wu, X., Zhang, Y., Han, M., Qie, R., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13161 · Cited by 52
The physiology of MASLD: molecular pathways between liver and adipose tissues
Lee, W., Kipp, Z. A., Bates, E. A., Pauss, S. N., Martinez, G. J., & Hinds, T. D. (2025) · Clinical Science · doi:10.1042/cs20257571 · Cited by 55
“Adipose tissue insulin resistance is generally characterized by an increased release of free fatty acids into the bloodstream despite hyperinsulinemia [195].”
Gao, J., Song, J., Du, ., & Mao, X. (2018) · Nutrients · doi:10.3390/nu10020242 · Cited by 46
Prevalence and Features of Impaired Glucose Tolerance in Young Underweight Japanese Women
Sato, M., Tamura, Y., Nakagata, T., Someya, Y., Kaga, H., Yamasaki, N., Kiya, M., Kadowaki, S., Sugimoto, D., Satoh, H., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab052 · Cited by 60
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Gastaldelli, A., Stefan, N., & Häring, H. (2021) · Diabetologia · doi:10.1007/s00125-021-05442-2 · Cited by 49
Self-citationDysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
Sehrawat, A., Mishra, J., Mastana, S. S., Navik, U., Bhatti, G. K., Reddy, P. H., & Bhatti, J. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166666 · Cited by 49
Chamomile as a potential remedy for obesity and metabolic syndrome
Bayliak, M. M., Dmytriv, T. R., Melnychuk, A. V., Strilets, N. V., Storey, K. B., & Lushchak, V. I. (2021) · EXCLI journal · doi:10.17179/excli2021-4013 · Cited by 55
“…including fatty liver, pro-inflammatory state and oxidative stress, hypertension, dyslipidemia, atherosclerosis, insulin resistance and type 2 diabetes (Grundy, 2004; Laclaustra et al., 2007; Matsuda and Shimomura, 2013; Gastaldelli et al., 2017; Marušić et al., 2021; Bayliak and Abrat, 2020).”
BackgroundKerr, A. G., Andersson, D. P., Dahlman, I. A., Rydén, M., & Arner, P. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319227 · Cited by 50
Key biomarkers in type 2 diabetes patients: A systematic review
Le, T. N., Bright, R., Truong, V. K., Li, J. Y. Z., Juneja, R., & Vasilev, K. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15991 · Cited by 55
“115,116 Second, diminished lipoprotein lipase activity is linked to a decline in triglyceride clearance.”
Ezeh, U., Chen, I. Y.-D., Chen, Y.-H., & Azziz, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa235 · Cited by 44
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
Shannon, C. E., Merovci, A., Xiong, J., Tripathy, D., Lorenzo, F., McClain, D. A., Abdul-Ghani, M. A., Norton, L., & DeFronzo, R. A. (2018) · Diabetes · doi:10.2337/db18-0439 · Cited by 44
“Insulin-resistant individuals manifest diminished insulin-stimulated glucose disposal in skeletal and cardiac muscle (5–7), adipocytes (8), liver (9), and gastrointestinal tract (10).”
BackgroundSelf-citationInglis, J. E., Kleckner, A. S., Lin, P., Gilmore, N. J., Culakova, E., VanderWoude, A., Mustian, K. M., Fernandez, I. D., Dunne, R. F., Deutsch, J. M., et al. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1807574 · Cited by 45
Glucose Tolerance is Linked to Postprandial Fuel Use Independent of Exercise Dose
Gilbertson, N. M., Eichner, N. Z. M., François, M. E., Gaitán, J. M., Heiston, E. M., WELTMAN, A. L., & Malin, S. K. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001667 · Cited by 46
Gaggini, M., Carli, F., Rosso, C., Younes, R., D’Aurizio, R., Bugianesi, E., & Gastaldelli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246333 · Cited by 47
Self-citationJørgensen, S. W., Hjort, L., Gillberg, L., Justesen, L., Madsbad, S., Brøns, C., & Vaag, A. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2020 · Cited by 43
Semnani-Azad, Z., Connelly, P. W., Bazinet, R. P., Retnakaran, R., Jenkins, D. J. A., Harris, S. B., Zinman, B., & Hanley, A. J. (2021) · Diabetes Care · doi:10.2337/dc20-1918 · Cited by 41
Chueire, V. B., & Muscelli, E. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000313 · Cited by 50
“This condition contributes to adipose tissue high lipid turnover, thereby increases plasma FFAs availability and concentration at fasting and after glucose or mixed meal ingestion (6).”
BackgroundRecent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Wawrzkiewicz–Jałowiecka, A., Lalik, A., & Soveral, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105226 · Cited by 50
“As a consequence, the dysfunction of adipose tissue frequently leads to obesity and other metabolic abnormalities [5], as well as other health problems such as non-alcoholic fatty liver disease (NAFLD) [6–10].”
BackgroundSun, H., Chang, X., Bian, N., An, Y., Liu, J., Leng, S., & Wang, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835154 · Cited by 48
Onaolapo, A. Y., & Onaolapo, O. J. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i7.99 · Cited by 52
Xin, Y., Wang, Y., Chi, J., Zhu, X., Zhao, H., Zhao, S., & Wang, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186505 · Cited by 47
Cai, X., Xia, L., Pan, Y., He, D., Zhu, H., Wei, T., & He, Y. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0418-x · Cited by 48
Fan, J., Gao, S., Wang, L. J., Qian, Z. L., Zhou, Z. Q., & Liu, X. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0029 · Cited by 42
“19 When b -cells cannot respond to IR and afford hyperinsulinemia some day, FPG may ultimately increase significantly, but this process is relatively long.”
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Ferreira, V., Grajales, D., & Valverde, Á. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158534 · Cited by 45
“In addition to the control of whole body energetic balance, adipose tissue also regulates glucose and lipid metabolism [16,58,76].”
BackgroundDiener, C., Reyes‐Escogido, M. D. L., Jiménez-Ceja, L. M., Matus, M. G., Navarro, C. M. G., Chu, N. D., Zhong, V., Tejero, M. E., Alm, E. J., Reséndis-Antonio, O., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602326 · Cited by 45
Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies
Hua, S., Liu, Q., Li, J., Fan, M., Yan, K., & Ye, D. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09661-1 · Cited by 40
Feline comorbidities: Pathophysiology and management of the obese diabetic cat
Clark, M., & Hoenig, M. E. (2021) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x211021540 · Cited by 62
DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
Romacho, T., Sell, H., Indrakusuma, I., Röhrborn, D., Castañeda, T. R., Jeleník, T., Markgraf, D. F., Hartwig, S., Weiß, J., Al‐Hasani, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2019 · Cited by 40
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 46
Self-citationZhang, K., Pan, H., Wang, L., Yang, H., Zhu, H., & Gong, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291350 · Cited by 40
Complex interplay among adiposity, insulin resistance and bone health
Ma, C., Tonks, K. T. T., Samocha‐Bonet, D., & Greenfield, J. R. (2018) · Clinical Obesity · doi:10.1111/cob.12240 · Cited by 38
Potential Roles of Purslane (Portulaca oleracea L.) as Antimetabolic Syndrome: A Review
Aini, N. S., Ansori, A. N. M., Kharisma, V. D., Syadzha, M. F., Widyananda, M. H., Murtadlo, A. A. A., Probojati, R. T., Ullah, M. E., Naw, S. W., Jakhmola, V., et al. (2022) · Pharmacognosy Journal · doi:10.5530/pj.2022.14.90 · Cited by 37
Gowd, V., Xiao, J., Wang, M., Chen, F., & Cheng, K. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100252 · Cited by 42
Adipocyte Gq signaling is a regulator of glucose and lipid homeostasis in mice
Kimura, T., Pydi, S. P., Wang, L., Haspula, D., Cui, Y., Lü, H., König, G. M., Kostenis, E., Steinberg, G. R., Gavrilova, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29231-6 · Cited by 37
Collins, K. A., Ross, L. M., Slentz, C. A., Huffman, K. M., & Kraus, W. E. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00480-5 · Cited by 43
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
Shirakawa, K., & Sano, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1044737 · Cited by 38
Levine, J. A., Han, J. M., Wolska, A. T., Wilson, S. R., Patel, T. P., Remaley, A. T., Periwal, V., Yanovski, J. A., & Demidowich, A. P. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.012 · Cited by 37
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · Hypertension Research · doi:10.1038/s41440-022-00987-0 · Cited by 33
Liver insulinization as a driver of triglyceride dysmetabolism
Cook, J. R., Hawkins, M. A., & Pajvani, U. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00843-6 · Cited by 35
El-sheikh, H. M., El-Haggar, S. M., & Elbedewy, T. A. E. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.035 · Cited by 38
Metadata
- Authors
- Gastaldelli, A., Gaggini, M., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-01-04
- Volume
- 66
- Issue
- 4
- Pages
- 815-822
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2571158149
- Cited by
- 344
- References
- 41
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 46 · 2021: 62 · 2020: 43 · 2019: 28 · 2018: 25 · 2017: 6
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- EU Horizon 2020 project EpoS (634413)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue insulin resistance, type 2 diabetes, impaired glucose tolerance, beta-cell function, free fatty acids, insulin resistance, obesity, glucose tolerance, Matsuda index
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Glucose Clamp Technique, Case-Control Studies, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.